118
Participants
Start Date
May 31, 2005
Primary Completion Date
June 30, 2007
Study Completion Date
November 30, 2007
topiramate
15 mg/kg/day
topiramate
5 mg/kg/day
topiramate
25 mg/kg/day
placebo
placebo
Birmingham
Mobile
Los Angeles
Denver
New Haven
Wilmington
Washington D.C.
Loxahatchee Groves
Miami
Orlando
Pensacola
Tampa
Augusta
Chicago
Park Ridge
Louisville
Shreveport
Boston
Ann Arbor
Dearborn
Saint Paul
Columbia
Kansas City
Springfield
St Louis
Cherry Hill
Newark
Buffalo
Mineola
Rochester
Stony Brook
Syracuse
Chapel Hill
Durham
Cincinnati
Cleveland
Danville
Hershey
Philadelphia
Pittsburgh
Providence
Charleston
Germantown
Fort Worth
Plano
Norfolk
Madison
Buenos Aires
Córdoba
Rio Negro
Santa Fe
Heidelberg West
Melbourne
Subiaco
Antwerp
Ghent
Leuven
Pulderbos
St. John's
Saskatoon
Chile
Santiago
Helsinki
Tampere
Bordeaux
Lille
Tours
Budapest
Chennai
Hyderabad Gpo
Kochi Ho
Mumbai
New Delhi
Pune
Petah Tikva
Monterrey
San Luis Potosí City
Heeze
Wellington
Bergen
Gdansk
Warsaw
Ekaterinburg Siberia
Moscow
Omsk Siberia
Samara
Cape Town Wc
Seoul
Madrid
Taipei
Bangkok
Chiang Mai
Donetsk
Kiev
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY